Suppr超能文献

左旋多巴:历史与治疗应用

Levodopa: History and Therapeutic Applications.

作者信息

Ovallath Sujith, Sulthana Bahiya

机构信息

James Parkinson's Movement Disorder Research Centre, Kannur Medical College, Kannur, Kerala, India.

出版信息

Ann Indian Acad Neurol. 2017 Jul-Sep;20(3):185-189. doi: 10.4103/aian.AIAN_241_17.

Abstract

Levodopa - the aromatic amino acid L-3,4-dihydroxy phenylalanine has held the attention of neurologists and pharmacologists alike for more than half a century. Even though extensive research has been done across the globe in treatment of Parkinson's disease, with different molecules, none could replace the gold standard treatment or provide complete relief for the debilitated. Although research brought us better tips and tricks to modulate the dopamine blood levels to balance between the desired and deleterious effects, it could never replace the basic substrate. From simple oral preparation to more advanced treatment like duodenal dopa administration for better efficacy and compliance, L-dopa has sure undergone scrutiny and stayed strong as the fundamental neurotransmitter replacement therapy to pave path for many more new therapeutic strategies. So as a token of gratitude to the revolutionary agent and pioneers behind it, a trip down the memory lane is in order.

摘要

左旋多巴——芳香族氨基酸L-3,4-二羟基苯丙氨酸,半个多世纪以来一直吸引着神经学家和药理学家的关注。尽管全球范围内针对帕金森病的治疗已经进行了广泛研究,涉及不同分子,但没有一种能够取代这一黄金标准治疗方法,也无法为患者提供完全缓解。尽管研究为我们带来了更好的方法来调节多巴胺血药浓度,以平衡预期效果和不良影响,但始终无法替代基本底物。从简单的口服制剂到更先进的治疗方法,如十二指肠给予多巴以提高疗效和依从性,左旋多巴无疑经受住了审视,并作为基本的神经递质替代疗法保持强劲势头,为更多新的治疗策略铺平道路。因此,为了向这一革命性药物及其背后先驱者表达敬意,回顾一下历史很有必要。

相似文献

1
Levodopa: History and Therapeutic Applications.
Ann Indian Acad Neurol. 2017 Jul-Sep;20(3):185-189. doi: 10.4103/aian.AIAN_241_17.
2
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Mov Disord. 2015 Jan;30(1):19-36. doi: 10.1002/mds.26120. Epub 2014 Dec 8.
3
The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
Mov Disord. 2015 Jan;30(1):4-18. doi: 10.1002/mds.26102. Epub 2014 Dec 9.
4
Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum.
Neuroscience. 2001;103(3):639-51. doi: 10.1016/s0306-4522(00)00588-1.
5
The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.
J Pharmacol Exp Ther. 2014 Oct;351(1):114-23. doi: 10.1124/jpet.114.216317. Epub 2014 Jul 29.
6
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.
7
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672). doi: 10.1098/rstb.2014.0184.
8
Treatment of Parkinson's disease: levodopa as the first choice.
J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4.
9
L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
Amino Acids. 2002;23(1-3):65-70. doi: 10.1007/s00726-001-0111-9.
10
Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Cortex. 2017 Aug;93:193-205. doi: 10.1016/j.cortex.2017.05.021. Epub 2017 Jun 7.

引用本文的文献

3
Maternal Intake of Laminarin Improves Infant Growth and Health by Fortifying Metabolite Profiles of Colostrum and Milk.
J Agric Food Chem. 2024 Nov 27;72(47):26178-26188. doi: 10.1021/acs.jafc.4c07560. Epub 2024 Nov 14.
4
Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response.
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):355-373. doi: 10.1146/annurev-pharmtox-022724-100847. Epub 2024 Dec 17.
5
Spatio-temporal expression of polyphenol oxidase unveils the dynamics of L-DOPA accumulation in faba bean ( L.).
Physiol Mol Biol Plants. 2024 May;30(5):839-850. doi: 10.1007/s12298-024-01449-2. Epub 2024 Apr 29.
6
7
Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease.
Biomedicines. 2024 Jan 8;12(1):130. doi: 10.3390/biomedicines12010130.
8
Prediction of dyskinesia in Parkinson's disease patients using machine learning algorithms.
Sci Rep. 2023 Dec 16;13(1):22426. doi: 10.1038/s41598-023-49617-w.
9
"Blind men and an elephant": The need for animals in research, drug safety studies, and understanding civilizational diseases.
Animal Model Exp Med. 2023 Dec;6(6):627-633. doi: 10.1002/ame2.12364. Epub 2023 Dec 7.

本文引用的文献

2
Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
Mov Disord. 2015 Aug;30(9):1222-8. doi: 10.1002/mds.26219. Epub 2015 Apr 2.
4
The history of parkinsonism: descriptions in ancient Indian medical literature.
Mov Disord. 2013 May;28(5):566-8. doi: 10.1002/mds.25420. Epub 2013 Mar 8.
5
Dual effects of L-DOPA on nigral dopaminergic neurons.
Exp Neurol. 2013 Sep;247:582-94. doi: 10.1016/j.expneurol.2013.02.009. Epub 2013 Feb 26.
6
The history of dopamine and levodopa in the treatment of Parkinson's disease.
Mov Disord. 2008;23 Suppl 3:S497-508. doi: 10.1002/mds.22028.
7
Chemical structure and sympathomimetic action of amines.
J Physiol. 1910 Oct 11;41(1-2):19-59. doi: 10.1113/jphysiol.1910.sp001392.
8
Concentration and distribution of "encephalin" in the brain of humans and animals.
Proc Soc Exp Biol Med. 1951 Jan;76(1):97-100. doi: 10.3181/00379727-76-18398.
9
Amino acids and amines as precursors of epinephrine.
Am J Physiol. 1951 Feb;164(2):476-9. doi: 10.1152/ajplegacy.1951.164.2.476.
10
[ON THE PRESENCE OF CATECHOLAMINES AND 3,4-DIHYDROXYPHENYLALANINE (DOPA) IN THE EYE].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 May 29;247:202-13. doi: 10.1007/BF00245964.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验